Loading…
Based on limited metadata, this FDA Warning Letter issued to Santiste Labs LLC on April 27, 2020, concerns pharmaceutical drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided. To understand the particular compliance issues and required corrective actions, the complete warning letter text would need to be reviewed.